Article

Two C-terminal sequence variations determine differential neurotoxicity between human and…

medRxiv · 2019 · Landeck, N.; Strathearn, K. E.; Ysselstein, D.; Buck, K.; Dutta, S.; Banerjee, S.; Lv, Z.; Hulleman, J. D.; Hindupur, J.; Lin, L.-K.; Padalkar, S.; McCabe, G. P.; Stanciu, L. A.; Lyubchenko, Y. L.; Kirik, D.; Rochet, J.-C.

Key facts

Title Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein
First author Landeck, N.; Strathearn, K. E.; Ysselstein, D.; Buck, K.; Dutta, S.; Banerjee, S.; Lv, Z.; Hulleman, J. D.; Hindupur, J.; Lin, L.-K.; Padalkar, S.; McCabe, G. P.; Stanciu, L. A.; Lyubchenko, Y. L.; Kirik, D.; Rochet, J.-C.
Journal medRxiv
Published Dec 31, 2019
DOI 10.1101/700377
Devices mentioned K810863, K954191, K982485
Product codes mentioned DBM, GIA, LFZ

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature